Choosing the best trastuzumab- based adjuvant chemotherapy regimen: Should we abandon anthracyclines?

Harold J. Burstein, Martine J. Piccart-Gebhart, Edith A. Perez, Gabriel N. Hortobagyi, Norman Wolmark, Kathy S. Albain, Larry Norton, Eric P. Winer, Clifford A. Hudis

Research output: Contribution to journal › Comment/debate › peer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'Choosing the best trastuzumab- based adjuvant chemotherapy regimen: Should we abandon anthracyclines?'. Together they form a unique fingerprint.